LUNAC Therapeutics
Latest round
- Series A
Last raised
- Sep 2019
Total raised
- $3.3M
Investors
- 2
About LUNAC Therapeutics
LUNAC Therapeutics Limited, founded in 2018 in Leeds, UK, specializes in the development of next-generation anticoagulants.LUNAC Therapeutics specializes in the development of next-generation anticoagulant therapies, specifically focusing on first-in-class oral and intravenous medications designed to treat and prevent life-threatening thrombotic events.LUNAC Therapeutics operates within a business model focusing on B2B transactions with hospitals, healthcare providers, and pharmacies for the distribution of their anticoagulant products. Revenue is generated through partnerships with healthcare institutions and potential licensing agreements for the commercialization of their therapies. The company is also planning to launch new products that enhance their current offerings and expand into new geographic markets, specifically targeting North America, Europe, and Asia by 2023.
Who invested in LUNAC Therapeutics
2 investors across 1 round
See all investors in LUNAC Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 20, 2019
Amount
$3.3M
Investors
Questions about LUNAC Therapeutics
Who invested in LUNAC Therapeutics?
LUNAC Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LUNAC Therapeutics raised?
LUNAC Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LUNAC Therapeutics last raise money?
LUNAC Therapeutics's most recent round on record is a Series A, in Sep 2019.
What does LUNAC Therapeutics do?
LUNAC Therapeutics Limited, founded in 2018 in Leeds, UK, specializes in the development of next-generation anticoagulants.
Where is LUNAC Therapeutics headquartered?
LUNAC Therapeutics is headquartered in Leeds, UK.
Which VCs invest in companies like LUNAC Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at LUNAC Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like LUNAC Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.